A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Experimental Treatment Gaining Traction Via Social Media
Retatrutide, which is still in research studies, is being advertised by online personalities for its supposed fat-burning properties. Viewers are urged to message these profiles privately for supplier links, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Separately, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors promote the drug there before directing customers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Experts Voice Worries
Nevertheless, doctors and chemists have warned that the sale of what remains an unapproved drug in the UK is worrisome and could result in individuals injecting products of uncertain source.
Some experts stated the demand for the experimental drug could be connected to the increasing price of approved slimming products such as Mounjaro.
Regulatory Position and Implementation
Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Service Reaction and Content Removal
According to TikTok, the service has taken down violative material and banned related keywords and query recommendations. The company said it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.
Digital Marketplace Operations
Investigations also found communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up groups with numerous of users, populated with images of slimming results, glowing reviews and detailed instructions for preparing or administering at home.
After moments of entering one community, a vendor posted contact information, where the majority of purchases occur. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.
Item Information and Costs
Inside these communities, messages show dark colored packages with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with purified liquid, or pre-filled pens typically sold at £160 for 20mg. When questioned how long a injector should last, vendors give conflicting responses ranging from a several days to “depends on your body”.
Service Moderation and Security Measures
A representative for the messaging service stated it regularly monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they cannot confirm. Although the research behind this drug is valid, these digital versions may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are using online platforms. But fake treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her staff has already encountered individuals injured by personal administration from unverified suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational product not yet authorized … may expose patients to potentially serious health risks”.
